Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non Previously Treated CD20+ Diffuse Large B-cell Lymphoma”

9 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 9 of 9 results

Testing effectiveness (Phase 2)Study completedNCT01195714
What this trial is testing

Study of Mini-Chop Plus Ofatumumab To Treat Cd 20+ Diffuse Large B-Cell Lymphoma In Patients Aged Over 80 Years

Who this might be right for
Non Previously Treated CD20+ Diffuse Large B-cell Lymphoma
The Lymphoma Academic Research Organisation 120
Early research (Phase 1)Study completedNCT02290951
What this trial is testing

Study to Investigate the Safety and Tolerability of Odronextamab in Patients With CD20+ B-Cell Malignancies

Who this might be right for
Non-Hodgkin LymphomaChronic Lymphocytic Leukemia
Regeneron Pharmaceuticals 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT03888105
What this trial is testing

Assess the Anti-Tumor Activity and Safety of Odronextamab in Adult Patients With B-cell Non-Hodgkin Lymphoma Who Have Been Previously Treated With Other Cancer Therapies

Who this might be right for
B-cell Non-Hodgkin Lymphoma (B-NHL)
Regeneron Pharmaceuticals 515
Testing effectiveness (Phase 2)Study completedNCT00438880
What this trial is testing

Agatolimod Sodium, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Recurrent or Refractory Non-Hodgkin Lymphoma

Who this might be right for
Adult Non-Hodgkin LymphomaExtranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid TissueNodal Marginal Zone Lymphoma+9 more
Mayo Clinic 38
Testing effectiveness (Phase 2)Study completedNCT00290667
What this trial is testing

Rituximab and Combination Chemotherapy in Treating Older Patients With Previously Untreated B-Cell Lymphoma

Who this might be right for
Lymphoma
German High-Grade Non-Hodgkin's Lymphoma Study Group 586
Testing effectiveness (Phase 2)Study completedNCT01087424
What this trial is testing

Mini-CHOP and Rituximab in Patients Aged Over 80 Years

Who this might be right for
Diffuse Large B-Cell Lymphoma
Lymphoma Study Association 150
Large-scale testing (Phase 3)Study completedNCT00003595
What this trial is testing

Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Previously Untreated HIV-Associated Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
National Cancer Institute (NCI) 120
Testing effectiveness (Phase 2)Study completedNCT00690560
What this trial is testing

Combination Chemotherapy, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Newly Diagnosed Large B-Cell Lymphoma

Who this might be right for
Lymphoma
Centre Antoine Lacassagne 30
Testing effectiveness (Phase 2)Study completedNCT00032019
What this trial is testing

Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Alliance for Clinical Trials in Oncology 78